参考文献:
〔1〕Mackenzie EJ, Mortimer RH. Thyroid nodule and thyroid cancer 〔J〕.MJA, 2004,180:242- 247.
〔2〕Nix P,Nicolaides A,Coatesworth AP.Thyroid cancer review1:presentationand investigation of thyroid cancer 〔J〕.Int J Clin Pract,2005,59:1459- 1463.
〔3〕Ferlay J, Bray F, Pisani P, et al. Cancer Inc Ferlay idence, Mortality andPrevalence Worldwide〔M〕. Lyon: IARC press, 2001.
〔4〕Uhry Z, Colonna M, Remontet L, et al.Estimating infra- national and nationalthyroid cancer incidence in France from cancer registries dataand national hospital discharge database〔J〕.Eur J Epidemiol, 2007,22:607- 614.
〔5〕Havat MJ,Howlader N,Reichman ME,et al.Cancer statistics,trends,andmultiple primary cancer analyses from the surveillance,epidemiology,and end results(SEER)program〔J〕.Oncologist,2007,12:20- 37.
〔6〕Capezzone M,Morabito E,Bellitti P,et al.Increasing incidence of thyroidcancer in Basilicata:an Italian study 〔J〕.J Endocrinol Invest,2007,30:507- 512.
〔7〕Prokopakis EP, Lachanas VA, Velegrakis GA,et al.Creased incidence ofpapillary thyroid cancer among total thyroidectomies in crete 〔J〕.OtolaryngolHead Neck Surg,2007,136: 560- 562.
〔8〕Vanuga P,Pura M,Plesko I,et al.Incidence of thyroid cancer in Slovakia:extensive evidence from one centre in the context of national data 〔J〕.Cas Lek Cesk,2007,146: 148- 152.
〔9〕Cheah WK.Thyroid cancer:diagnosis and management 〔J〕.SingaporeMed J,2007,48:107- 112.
〔10〕钱碧云, 陈可欣, 何敏,等.天津市区甲状腺癌流行状况调查〔J〕.中国肿瘤临床, 2005, 32( 4) :218- 221.
〔11〕应敏刚, 陈建顺, 肖景榕,等.长乐市1988—2002 年恶性肿瘤发病率时间趋势分析〔J〕.中国肿瘤, 2005, 14( 1) :32- 34.
〔12〕陈银成, 陈灼怀, 关弘, 等. 甲状腺髓样癌的诊断与鉴别诊断〔J〕. 诊断病理学杂志, 2005, 12( 5) : 345- 347.
〔13〕Albores SJ,Henson DE,Glazer E,et al.Changing patterns in the incidenceand survival of thyroid cancer with follicular phenotype- papillary,follicular,and anaplastic:a morphological and epidemiological study 〔J〕.Endocr Pathol,2007,18:1- 7.
〔14〕Truong T, Rougier Y, Dubourdieu D, et al.Time trends and geographicvariations for thyroid cancer in New Caledonia,a very high incidencearea(1985- 1999)〔J〕.Eur J Cancer Prev,2007,16:62- 70.
〔15〕Lubina A,Cohen O,Baechana M,et al.Time trends of incidence rates ofthyroid cancer in Israel:what might explain the sharp increase〔J〕.Thyroid,2006,16:1033- 1040.
〔16〕Di CJ,Vasko V, Savchenko V, et al.Ret/PTC1 and ret/PTC3 in thyroidtumors from Chernobyl liquidators :comparison with sporadic tumorsfrom Ukrainian and French patients〔J〕.Endocri Relat Cancer,2005,12:173- 183.
〔17〕Cardis E,Kesminiene A, Ivanov V, et al.Risk of thyroid cancer after exposureto 131I in childhood〔J〕.J Natl Cancer Inst,2005,77:724- 732.
〔18〕Lope V, Pérez GB, Aragonés N,et al.Occupational exposure to ionizingradiation and electromagnetic fields in relation to the risk of thyroidcancer in Sweden〔J〕.Scand JWork Environ Health,2006,32:276- 284.
〔19〕Baker SR,Bhatti WA.The thyroid cancer epidemic:is it the dark side ofthe CT revolution〔J〕.Eur J Radiol,2006,60:67- 69.
〔20〕Ilias I,Alevizaki M,Lakka PE.Differentiated thyroid cancer in Greece:1963- 2000.Relation to demographic and environmental factors〔J〕.Hormones(Athens),2002,1:174- 178.
〔21〕关海霞, 单忠燕, 米小铁,等.普遍食盐碘化前后甲状腺癌发病变化的11 年病理资料分析〔J〕.中国医科大学学报, 2006, 35( 3) :284-285.
〔22〕Ryan TB, Chun YF, Ehab YH. Well - differentiated carcinoma of thethyroid〔J〕. Otolaryngol Clin NAm, 2003, 36:73- 90.
〔23〕Larson SD, Jackson LN, Riall TS,et al.Increased incidence of well- differentiatedthyroid cancer associated with Hashimoto thyroiditis and therole of the PI3K/Akt pathway〔J〕.J AmColl Surg,2007,204:764- 773.
〔24〕Boi F,Lai ML,Marziani B,et al.High prevalence of suspicious cytologyinthyroid nodules associated with positive thyroid autoantibodies 〔J〕.EurJ Endocrinol,2005,153:637- 642.
〔25〕Hishinuma A,Fukata S,Kakudo K, et al.High incidence of thyroid cancerin long- standing goiters with thyroglobulin mutation 〔J〕.Thyroid,2005,15:1079- 1084.
〔26〕Karges B, Krause G, Homoki J,et al.TSHreceptormutation V509Acausesfamilial hyperthyroidismby interhelical constraints between transmembrancehelices TMH3 and TMH5〔J〕.J Endocrinol,2005,186:377- 385.
〔27〕Lee SH, Kim KM, Jung BH, et al. Estrogens in female thyroid cancer:alteration of urinary profiles in pre- and post- operative cases〔J〕.CancerLett,2003,189:27- 32.
〔28〕Vivacqua A, Bonofiglio D, Albanito L,et al.17beta- estradiol, genistein,and 4- hydroxytamoxifen induce the proliferation of thyroid cancer cellsthrough the g protein - coupled receptor GPR30 〔J〕.Mol Pharmacol,2006,70:1414- 1423.
〔29〕Guignard R, Truong T, Rougier Y, et al.Alcohol drinking, tobacco smoking,and anthropometric characteristics as risk factors for thyroid cancer:a countrywide case- control study in NewCaledonia 〔J〕.Am J Epidemiol,2007,166: 1140- 1149.
〔30〕Nagano J, Mabuchi K, Yoshimoto Y,et al.A case- control study in Hiroshimaand Nagasaki examining non- radiation risk factors for thyroidcancer〔J〕J Epidemiol,2007,17:76- 85.
〔31〕Ihre LC.Are possible risk factors for differentiated thyroid cancer ofprognostic importance〔J〕.Thyroid,2006,16:659- 666.
